Menu
Search
|

Menu

Close
X

Natus Medical Inc BABY.OQ (NASDAQ Stock Exchange Global Select Market)

30.85 USD
+0.75 (+2.49%)
As of Feb 17
chart
Previous Close 30.10
Open 30.15
Volume 80,059
3m Avg Volume 108,281
Today’s High 30.85
Today’s Low 30.15
52 Week High 43.55
52 Week Low 28.05
Shares Outstanding (mil) 33.15
Market Capitalization (mil) 1,340.90
Forward P/E 67.43
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.33 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY17
501
FY16
382
FY15
376
EPS (USD)
FY17
-0.623
FY16
1.320
FY15
1.141
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
67.43
32.90
Price to Sales (TTM)
vs sector
3.01
5.77
Price to Book (MRQ)
vs sector
3.14
5.41
Price to Cash Flow (TTM)
vs sector
32.57
23.42
Total Debt to Equity (MRQ)
vs sector
25.67
16.52
LT Debt to Equity (MRQ)
vs sector
25.67
12.22
Return on Investment (TTM)
vs sector
3.83
14.43
Return on Equity (TTM)
vs sector
4.58
16.13

EXECUTIVE LEADERSHIP

Robert Gunst
Independent Chairman of the Board, Since 2004
Salary: --
Bonus: --
James Hawkins
President, Chief Executive Officer, Director, Since 2013
Salary: $750,000.00
Bonus: --
Jonathan Kennedy
Chief Financial Officer, Executive Vice President, IR Contact Officer, Since 2016
Salary: $440,000.00
Bonus: --
Austin Noll
Vice President and General Manager - Neurology Strategic Business Unit, Since 2012
Salary: $340,000.00
Bonus: --
D. Christopher Chung
Vice President - Medical Affairs, Quality & Regulatory, Since 2011
Salary: $286,000.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

6701 Koll Center Pkwy Ste 120
PLEASANTON   CA   94566-8061

Phone: +1925.2236700

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Company is organized into three strategic business units: Neurology, Newborn Care and Otometrics.

SPONSORED STORIES